Download or read book North American Biotechnology Enterprises written by Sophie Veilleux and published by . This book was released on 2010 with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt: Emerging markets are at the forefront of managers' strategic planning in many sectors, and they are moving into center stage in the biotechnology and pharmaceutical industries. Restricted budgets, heavy fixed costs, and low population growth in Western countries signal diminishing revenues and the need to increase effectiveness and efficiency in the therapeutic domain. Meanwhile, the growth of large, eventually lucrative markets for therapeutic products in emerging countries represent new markets for existing products and the opportunity to serve the specific needs of local populations. In addition, the rapid development of local biotech industries in certain emerging countries will create eventual partners to take advantage of these new markets. Are biotech firms poised to respond to these challenges? This benchmark study describes the involvement of two samples drawn from biotechnology clusters in the United States and in Canada in terms of their international alliance activities in general and, more specifically, their alliance activities in emerging markets. Results indicate that while international alliances are predominant, emerging countries alliances represent a very small portion of these. The absence of venture capital appears to be a deciding factor for firms that do choose emerging market partners. Results create a benchmark for future research.--Résumé de l'éditeur.
Download or read book North American Biotechnology Enterprises written by Sophie Veilleux and published by . This book was released on 2010 with total page 18 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book The Biotechnologists written by Stephanie Jones and published by Springer. This book was released on 1991-12-12 with total page 277 pages. Available in PDF, EPUB and Kindle. Book excerpt: In The Biotechnologists, a series of outstanding biotechnology entrepreneurs - from the USA, the UK and continental Europe - tell their own stories of how they played a part in the evolution of the biotechnology companies they founded and/or now run. The book also looks at the role of venture capital and other forms of financing through their key stages of growth. A detailed introduction outlines the emergence of the biotech boom and its progress to date. A glossary explains scientific terms.
Download or read book North American Biotechnology Directory written by and published by . This book was released on 1997 with total page 534 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book From Breakthrough to Blockbuster written by Donald L. Drakeman and published by Oxford University Press. This book was released on 2022 with total page 241 pages. Available in PDF, EPUB and Kindle. Book excerpt: "Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. How could a large collection of small companies, most with fewer than 50 employees, compete in one of the world's most breathtakingly expensive and highly regulated industries? This book shows how biotech companies have met the challenge by creating nearly 40% more of the most important treatments for unmet medical needs. Moreover, they have done so with much lower overall costs. The book focuses on both the companies themselves and the broader biotech ecosystem that supports them. Its portrait of the crucial roles played by academic research, venture capital, contract research organizations, the capital markets, and pharmaceutical companies shows how a supportive environment enabled the entrepreneurial biotech industry to create novel medicines with unprecedented efficiency. In doing so, it also offers insights for any industry seeking to innovate in uncertain and ambiguous conditions. Looking to the future, it concludes that biomedical research will continue to be most effective in the hands of a large group of small companies as long as national healthcare policies allow the rest of the ecosystem to continue to thrive"--
Download or read book The U S Biotechnology Industry written by Jon Paugh and published by . This book was released on 1997 with total page 148 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Intellectual Capital and the Birth of U S Biotechnology Enterprises written by Lynne G. Zucker and published by . This book was released on 1994 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt: We examine the relationship between the intellectual capital of scientists making frontier discoveries, the presence of great university bioscience programs, the presence of venture capital firms, other economic variables, and the founding of U.S. biotechnology enterprises during 1976-1989. Using a linked cross-section/time- series panel data set, we find that the timing and location of the birth of biotech enterprises is determined primarily by intellectual capital measures, particularly the local number of highly productive 'star' scientists actively publishing genetic sequence discoveries. Great universities are likely to grow and recruit star scientists, but their effect is separable from the universities. When the intellectual capital measures are included in our poisson regressions, the number of venture capital firms in an area reduces the probability of foundings. At least early in the process, star scientists appear to be the scarce, immobile factors of production. Our focus on intellectual capital is related to knowledge spillovers, but in this case 'natural excludability' permits capture of supranormal returns by scientists. Given this reward structure technology transfer was vigorous without any special intermediating structures. We believe biotechnology may be prototypical of the birth patterns in other innovative industries.
Download or read book Meeting the Challenge written by Jon Paugh and published by DIANE Publishing. This book was released on 1998-08 with total page 109 pages. Available in PDF, EPUB and Kindle. Book excerpt: For more than a decade, there has been widespread & increasing concern that the ability of the U.S. to achieve sustained economic growth & long-term prosperity is adversely affected by declining industrial competitiveness. This report on the U.S. biotechnology industry examines the structure of the industry & the current & emerging markets for biotechnology products. It discusses the factors likely to be critical in determining the future competitiveness of the industry: technology infrastructure & Fed. res. initiatives, capital formation, the U.S. health care system, tax policies, the regulatory environment, foreign competitors, & trade issues.
Download or read book Competitiveness of the U S Biotechnology Industry written by United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Science, Technology, and Space and published by . This book was released on 1994 with total page 80 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Science Business written by Gary P. Pisano and published by Harvard Business Press. This book was released on 2006 with total page 278 pages. Available in PDF, EPUB and Kindle. Book excerpt: Why has the biotechnology industry failed to perform up to expectations? This book attempts to answer this question by providing a critique of the industry. It reveals the causes of biotech's problems and offers an analysis on how the industry works. It also provides prescriptions for companies, seeking ways to improve the industry's performance.
Download or read book Directory of Biotechnology Companies written by M. J. Sullivan and published by . This book was released on 1991-11 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Directory of Biotechnology Companies in the U S written by M. J. Sullivan and published by . This book was released on 1991-10 with total page 240 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Biotechnology written by Ronald P. Evens and published by CRC Press. This book was released on 2020-06-04 with total page 182 pages. Available in PDF, EPUB and Kindle. Book excerpt: The over-riding premise for biotechnology in this book is bringing novel products to market to substantially advance patient care and disease mitigation. Biotechnology, over its relatively brief existence of 40 years, has experienced a mercurial growth. The vast educational need for biotechnology information in this rapidly burgeoning field is a basic rationale here. However a more prominent underpinning is that, bringing biotech products to market for patient care involves success in the following four areas of engagement simultaneously - scientific advances for healthcare technologies, novel and varied products for untreated diseases, regulatory authorities, and biotech companies. Features Comprehensive coverage of biotechnology science topics used in development and manufacturing Addresses all the scientific technologies within biotechnology responsible for products on the market and the pipeline Presents business issues such as marketing and sales of the products, as well as companies engaged, and how biotech business has evolved
Download or read book Directory of Biotechnology Companies written by M. J. Sullivan and published by . This book was released on 1991-05 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Star Scientists Institutions and the Entry of Japanese Biotechnology Enterprises written by Michael R. Darby and published by . This book was released on 1996 with total page 60 pages. Available in PDF, EPUB and Kindle. Book excerpt: Advance of science and its commercial applications are in a close, symbiotic relationship in the U.S. biotechnology industry. Comparing Japan and the U.S., the structure of the science appears broadly similar, but the organization of the biotechnology industry is quite dissimilar. In the U.S., some 77 percent of new biotechnology enterprises (NBEs) were dedicated new biotechnology firms (NBFs) started for this purpose while 88 percent of Japanese biotech firms in our data base were subunits of existing firms (NBSs). We report pooled poisson regression estimates of the relation of NBE births in Japan to top-producing is at work in Japan and America, stars in Japan induce entry of significantly fewer NBEs than in the U.S. and preexisting economic activity plays a greater role. We find no such significant difference for entry of keiretsu-member and nonmember firms within Japan. We relate the significant Japan-U.S. differences to Japan's relatively compact geography and institutional differences between the higher-education and research funding systems, the venture-capital and IPO markets, cultural characteristics and incentive systems which impact scientists' entrepreneurialism, and tort-liability exposures. The relative importance of these factors and whether differences in organization of biotechnology result in substantial differences in productivity and international competitiveness are issues for future research.
Download or read book The Biotechnology Business Environment in North American and Europe written by Hermann A. M. Mucke and published by . This book was released on 2000 with total page pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Biotechnology Guide U S A written by Mark D. Dibner and published by Greenwood. This book was released on 1995 with total page 714 pages. Available in PDF, EPUB and Kindle. Book excerpt: Profiles over 1,300 companies active in biotechnology, lists venture capital firms, and analyzes the biotechnology industry. The data on companies includes the names of officers and directors, type of financing and names of investors when applicable, budget for research and development, revenues, number of employees, primary focus, search terms, and products on the shelf and in the oven. In addition to the main listing, which is alphabetical by company name, firms are listed by location, areas of interest such as biomass conversion and fungi, and key biotechnology areas such as Alzheimer's Disease and gene therapy. Other sections report on mergers, acquisitions, and fundraising; and analyze such aspects of the industry as funding, public firms, and resources in commercial biotechnology. The 1989 and 1991 editions were published by Stockton Press, New York; the 1995 and 1997 editions by IBI. Annotation copyrighted by Book News, Inc., Portland, OR
